AHCPR guidelines difficult to implement, HHS Inspector General survey concludes.
Executive Summary
AHCPR GUIDELINE IMPLEMENTATION DIFFICULTY CITED BY 63% OF USERS in an HHS Office of the Inspector General survey of health care organizations using the clinical practice guidelines developed by the Agency for Health Care Policy & Research. According to the survey, "uncertainty about how to implement the guidelines was the most frequently cited obstacle to use," cited by 43% of respondents. While 63% of the respondents cited obstacles to implementation, 43% claimed uncertainty. Examples identified by the IG include: a nursing home staff that found a guideline difficult to read and understand; a hospital that was not sure how to use a diagnostic tool recommended in a guideline; and a hospital unsure about "the extent to which it need comply with the guideline."
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth